HIV-1 mucosal vaccine (Guangzhou Institutes of Biomedicine and Health/Tsinghua University/The University of Hong Kong)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHIV-1 mucosal vaccine (Guangzhou Institutes of Biomedicine and Health/Tsinghua University/The University of Hong Kong)
Drug Alias NameAIDS mucosal vaccine (Guangzhou Institutes of Biomedicine and Health/Tsinghua University/University of Hong Kong)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionB-lymphocyte stimulantsT lymphocytes stimulantsHIV replication inhibitors
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesGuangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Hong KongGuangzhou Institute Of Biomedicine And Health, Chinese Academy Of SciencesTsinghua University
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A